EG210155 Inhibitors
EG210155 inhibitors are a class of chemical compounds that specifically target and modulate the activity of a molecule or protein designated as EG210155. While the precise biological function of EG210155 may not be fully elucidated, it is likely a protein involved in a specific cellular pathway, possibly playing a critical role in processes such as signal transduction, enzyme activity, or regulatory functions within the cell. EG210155 inhibitors are designed to bind to this target, thereby altering its function or interaction with other cellular components. This interference allows researchers to investigate the role of EG210155 in various biological processes, providing insights into its significance in maintaining cellular functions and homeostasis.
The mechanism of action for EG210155 inhibitors typically involves binding to specific sites on the EG210155 molecule, such as its active site if it functions as an enzyme or an allosteric site if it regulates interactions with other proteins or molecules. By binding to these sites, the inhibitors can block the normal activity of EG210155, preventing it from carrying out its role in the cell. This could result in the disruption of downstream signaling pathways, alterations in metabolic processes, or changes in the cellular environment that depend on the proper function of EG210155. The study of EG210155 inhibitors allows researchers to dissect the biological pathways in which EG210155 is involved, offering a clearer understanding of how this protein contributes to the overall functioning of the cell. Through such investigations, scientists can uncover the molecular mechanisms that underlie complex cellular processes, helping to map out the intricate networks that govern cellular behavior and response to internal and external stimuli.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tirofiban-d6 | 144494-65-5 (unlabeled) | sc-475655 | 1 mg | $450.00 | ||
Direct inhibitor disrupting cell-cell junction maintenance by targeting platelet integrin αIIbβ3, crucial for platelet aggregation and adhesion, indirectly impacting Lypd11-mediated processes associated with cell adhesion. | ||||||
Sivelestat | 127373-66-4 | sc-203938 | 1 mg | $105.00 | 2 | |
Direct inhibitor blocking neutrophil elastase activity, impacting positive regulation of neutrophil degranulation. By hindering elastase, this compound indirectly influences Lypd11's function in the regulation of this immune response pathway. | ||||||
Cilengitide | 188968-51-6 | sc-507335 | 5 mg | $215.00 | ||
Direct inhibitor targeting integrins, disrupting the integrin-mediated signaling pathway. By inhibiting integrin αvβ3, crucial for cellular adhesion and migration, this compound directly inhibits the pathway where Lypd11 is predicted to play a role. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Indirect inhibitor modulating cell-cell junction maintenance by disrupting the Nrf2 pathway. By inhibiting aldehyde dehydrogenase, this compound indirectly influences Nrf2, impacting Lypd11-mediated processes associated with cell adhesion. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Indirect inhibitor impacting neutrophil degranulation by inhibiting NF-κB. By disrupting NF-κB activation, this compound indirectly influences Lypd11's function in the positive regulation of neutrophil degranulation. | ||||||
FAK Inhibitor 14 | 4506-66-5 | sc-203950 sc-203950A | 10 mg 50 mg | $109.00 $238.00 | 86 | |
Direct inhibitor targeting Focal Adhesion Kinase (FAK), disrupting integrin-mediated signaling. By inhibiting FAK, this compound directly inhibits the pathway where Lypd11 is predicted to be involved, affecting cellular processes associated with adhesion. | ||||||
Glycyrrhizic acid | 1405-86-3 | sc-279186 sc-279186A | 1 g 25 g | $57.00 $333.00 | 7 | |
Indirect inhibitor influencing cell-cell junction maintenance by inhibiting TGF-β. By blocking TGF-β activation, this compound indirectly impacts Lypd11-mediated processes associated with cell adhesion. | ||||||
Formoterol | 73573-87-2 | sc-337847 | 100 mg | $571.00 | ||
Indirect inhibitor affecting neutrophil degranulation by modulating β2-adrenergic receptor signaling. By activating β2-adrenergic receptors, this compound indirectly influences Lypd11's function in the positive regulation of neutrophil degranulation. | ||||||
Rottlerin | 82-08-6 | sc-3550 sc-3550B sc-3550A sc-3550C sc-3550D sc-3550E | 10 mg 25 mg 50 mg 1 g 5 g 20 g | $84.00 $166.00 $302.00 $2091.00 $5212.00 $16657.00 | 51 | |
Indirect inhibitor impacting cell-cell junction maintenance through PKCδ inhibition. By blocking PKCδ, this compound indirectly influences Lypd11-mediated processes associated with cell adhesion. | ||||||
GM 6001 | 142880-36-2 | sc-203979 sc-203979A | 1 mg 5 mg | $77.00 $270.00 | 55 | |
Direct inhibitor targeting matrix metalloproteinases (MMPs), disrupting extracellular matrix dynamics. By inhibiting MMPs, this compound directly impacts the integrin-mediated signaling pathway where Lypd11 is predicted to play a role, affecting cellular adhesion. | ||||||